BSEInsider Trading / SAST17h ago · 25 Sept 2026, 06:09 pm
Attached
Dr. Lal PathLabs Ltd · 539524
✦ AI SummaryResults
Dr. Lal PathLabs Ltd has announced the closure of its trading window from October 1, 2026, to November 6, 2026, ahead of its board meeting on November 4, 2026, to consider the un-audited financial results for the quarter and half-year ending September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
6963c623-c6fd-49a0-88b8-71511a20208c.pdf
View document text
September 25, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Corporate Relationship Department
Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers
Bandra Kurla Complex, Bandra (E) Dalal Street
Mumbai – 400 051 Mumbai – 400 001
Symbol: LALPATHLAB Scrip Code: 539524
Sub: Intimation of Board Meeting and Closure of Trading Window
Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015
Dear Sir/ Madam,
This is to inform you that a meeting of the Board of Directors is scheduled to be held on
Wednesday, November 04, 2026, to inter-alia consider and approve the un-audited
(Standalone & Consolidated) Financial Results of the Company for the Quarter and Half
Year ending on September 30, 2026.
Further, in accordance with the provisions of the SEBI (Prohibition of Insider Trading)
Regulations, 2015 and Company's Code for Prevention of Insider Trading, the Trading
Window for dealing in Securities of the Company shall be closed from October 1, 2026,
to November 06, 2026 (both days inclusive).
We request you to kindly take the same on record.
Thanking You,
Yours Faithfully,
For Dr. Lal PathLabs Limited
Vinay Gujral
Company Secretary & Compliance Officer